BioArctic's Partner Eisai Says Leqembi Approved In Hong Kong For Alzheimer's Disease Treatment
11/7 05:13
(RTTNews) - BioArctic AB's partner Eisai announced that the Department of Health in Hong Kong has approved Leqembi for treatment of Alzheimer's disease. Treatment with Leqembi should be initiated in patients with mild cognitive impairment or mild dementia stage of disease, the po...